High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
Background. High calcineurin inhibitor (CNI) intrapatient variability (IPV) has been associated with poor kidney allograft outcomes. However, the relationship between early allograft histological changes, their progression, and CNI-IPV is less well studied. Hence, we evaluated effect of CNI-IPV defi...
Main Authors: | Akhil Sharma, MD, Aravind Cherukuri, MD, PhD, Rajil B. Mehta, MD, Puneet Sood, MD, Sundaram Hariharan, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-02-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000862 |
Similar Items
-
Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
by: Itunu Owoyemi, MD, et al.
Published: (2021-07-01) -
Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation
by: Didem Turgut, et al.
Published: (2021-01-01) -
Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
by: Hyejin Mo, MD, et al.
Published: (2019-06-01) -
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients
by: Sommerer Claudia, et al.
Published: (2010-01-01) -
Chromoblastomycosis in a renal allograft recipient on calcineurin inhibitor-free immunosuppression
by: P K Bipi, et al.
Published: (2019-01-01)